BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20638810)

  • 1. A novel and rapid LC/MS/MS assay for bioanalysis of Azurin p28 in serum and its pharmacokinetics in mice.
    Gorman GS; Coward LU; Freeman L; Noker PE; Beattie CW; Jia L
    J Pharm Biomed Anal; 2010 Dec; 53(4):991-6. PubMed ID: 20638810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.
    Jia L; Gorman GS; Coward LU; Noker PE; McCormick D; Horn TL; Harder JB; Muzzio M; Prabhakar B; Ganesh B; Das Gupta TK; Beattie CW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):513-24. PubMed ID: 21085965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies.
    Puttrevu SK; Laxman TS; Tripathi AK; Yadav AK; Verma SK; Mishra A; Pradhan R; Verma NK; Ghosh JK; Bhatta RS
    J Pharm Biomed Anal; 2019 May; 169():116-126. PubMed ID: 30851514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
    Li W; Luo S; Rebello S; Flarakos J; Tse FL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
    Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
    Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
    J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of Kirenol and ent-16β,17-dihydroxy-kauran-19-oic acid from Herba Siegesbeckiae in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies.
    Huo L; Jiang Z; Lei M; Wang X; Guo X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():18-24. PubMed ID: 24008120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
    Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
    J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an LC-MS/MS method for the determination of a novel thienoquinolin urea transporter inhibitor PU-48 in rat plasma and its application to a pharmacokinetic study.
    Zhang ZY; Wang X; Liu D; Zhang H; Zhang Q; Lu YY; Li P; Lou YQ; Yang BX; Lu C; Lou YX; Zhang GL
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC-MS/MS after oral administration of the Swertia pseudochinensis extract.
    Sheng N; Zhi X; Yuan L; Zhang Z; Jia P; Zhang X; Zhang L; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():75-83. PubMed ID: 25086416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of asperosaponin VI and its active metabolite hederagenin in rat plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.
    Zhu H; Ding L; Shakya S; Qi X; Hu L; Yang X; Yang Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3407-14. PubMed ID: 21963276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studies.
    Ramalingam P; Ko YT
    J Pharm Biomed Anal; 2016 Feb; 119():71-5. PubMed ID: 26657178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an LC-ESI-MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice.
    Hallur G; Purra BR; Sulochana SP; Saini NK; Daram P; Zainuddin M; Mullangi R
    J Pharm Biomed Anal; 2018 May; 153():260-266. PubMed ID: 29518645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
    Zhai Y; Li P; Wang M; Gong M; Qiu F
    Biomed Chromatogr; 2016 Feb; 30(2):105-10. PubMed ID: 26031660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated LC-MS/MS Method for the Determination of Scopoletin in Rat Plasma and Its Application to Pharmacokinetic Studies.
    Zeng Y; Li S; Wang X; Gong T; Sun X; Zhang Z
    Molecules; 2015 Oct; 20(10):18988-9001. PubMed ID: 26492227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an LC-MS/MS method for the determination of DPHB in rat plasma and its application in pharmacokinetic studies.
    Wen Q; Li HL; Chen F; Gong JW; Guan WW; Fu NG; Tan YF
    Biomed Chromatogr; 2018 Dec; 32(12):e4373. PubMed ID: 30133708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
    Gu GZ; Xia HM; Pang ZQ; Liu ZY; Jiang XG; Chen J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):449-56. PubMed ID: 21251889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.